Bank of America’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64K | Buy |
8,565
+6,909
| +417% | +$51.6K | ﹤0.01% | 5722 |
|
|
2025
Q1 | $16.2K | Buy |
1,656
+41
| +3% | +$401 | ﹤0.01% | 5985 |
|
|
2024
Q4 | $8.74K | Buy |
1,615
+855
| +113% | +$4.63K | ﹤0.01% | 6092 |
|
|
2024
Q3 | $4.78K | Sell |
760
-4
| -0.5% | -$25 | ﹤0.01% | 6096 |
|
|
2024
Q2 | $4.84K | Sell |
764
-3,011
| -80% | -$19.1K | ﹤0.01% | 6124 |
|
|
2024
Q1 | $31K | Sell |
3,775
-3,730
| -50% | -$30.6K | ﹤0.01% | 5775 |
|
|
2023
Q4 | $62.6K | Buy |
7,505
+1,367
| +22% | +$11.4K | ﹤0.01% | 5615 |
|
|
2023
Q3 | $79.1K | Buy |
6,138
+4,782
| +353% | +$61.6K | ﹤0.01% | 5464 |
|
|
2023
Q2 | $21.7K | Buy |
1,356
+1,192
| +727% | +$19K | ﹤0.01% | 5815 |
|
|
2023
Q1 | $2.15K | Buy |
164
+152
| +1,267% | +$1.99K | ﹤0.01% | 6377 |
|
|
2022
Q4 | $90 | Buy |
+12
| New | +$90 | ﹤0.01% | 6861 |
|